Cite
HARVARD Citation
Hill, E. et al. (n.d.). 130: Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): initial outcomes from 2 years' experience at the Oxford Cancer Centre, Oxford University Hospitals NHS Trust. Lung cancer. pp. S47-. [Online].